The present disclosure relates to methods and compositions for treating cancer with a diaryl macrocycle in combination with an inhibitor of MAPK/ERK kinase-1 and -2 (MEK1 and MEK2; MAP2K1 and MAP2K2), such as trametinib.
Combination therapy involving diaryl macrocyclic compounds
2022-06-30
Patent
Electronic Resource
English
IPC: | B60H ARRANGEMENTS OR ADAPTATIONS OF HEATING, COOLING, VENTILATING, OR OTHER AIR-TREATING DEVICES SPECIALLY FOR PASSENGER OR GOODS SPACES OF VEHICLES , Anordnung oder Einbau der Heizung, Kühlung, Lüftung oder anderer Luftbehandlungsvorrichtungen für die Fahrzeugräume für Reisende oder Fracht / F24F Klimatisierung , AIR-CONDITIONING / F25B Kältemaschinen, Kälteanlagen oder Kälteverfahren , REFRIGERATION MACHINES, PLANTS, OR SYSTEMS |
COMBINATION THERAPY INVOLVING DIARYL MACROCYCLIC COMPOUNDS
European Patent Office | 2024
|COMBINATION THERAPY INVOLVING DIARYL MACROCYCLIC COMPOUNDS
European Patent Office | 2021
|Combination therapy involving diaryl macrocyclic compounds
European Patent Office | 2022
|COMBINATION THERAPY INVOLVING DIARYL MACROCYCLIC COMPOUNDS
European Patent Office | 2021
|Use of electropolymerized films of macrocyclic compounds in direct methanol fuel cell components
Online Contents | 2004
|